The extent to which earlier age of onset (AO) is a reflection of increased genetic risk for major depression (MD) is still unknown. Previous biometrical research has provided mixed empirical evidence for the genetic overlap of AO with MD. If AO is demonstrated to be relevant to molecular polygenic risk for MD, incorporation of AO as a phenotype could enhance future genetic studies.
INTRODUCTION
Age at onset (AO) has been considered a potential quantitative indicator of underlying genetic risk for major depression (MD). However, the nature of any association of AO with genetic risk for MD is still unclear, and to date, twin and family research has provided mixed evidence to support this theory. Over the last several decades, multiple studies have observed that early AO is associated with increased familial risk (Holmans et & Baron, 1981; Weissman et al., , 1987 with many others finding no association (Harrington et al., 1997; Kendler et al., 1994; Weissman & Wickramaratne, 2000) . Contributing to the mixed evidence is the fact that AO has been studied at a variety of age thresholds, with some studies defining early-onset at under 18, while others examine the presence of MD at 30 years and younger. Differences in age thresholds have an impact on the study's generalizability and interpretability.
Family studies traditionally seek to compare the risk of disease in first-degree relatives to the risk found in the general population, and this is termed relative risk (RR). An increase in RR for family members has been predicted by an earlier AO in MD probands (Bland, Newman, & Orn, 1986; Cadoret, Woolson, & Winokur, 1977; Klein et al., 1999; Mendlewicz & Baron, 1981; Price, Kidd, & Weissman, 1987; Stancer, Persad, Wagener, & Jorna, 1987; Weissman et al., , 1993 Weissman, Gershon et al., 1984) . Family studies focusing on childhood-onset MD have also found an increase in severity and rate of affective disorders in relatives of children with MD (Todd et al., 1993) as well as compared to adult MD probands and their families (Neuman et al., 1997) .
This relationship was also found in the reverse, wherein one study of children of MD parents showed an increased risk of psychopathology and earlier onset of MD . However, other family studies have not found significant support for differences in genetic influences on MD predicted by AO (Fernandez-Pujals et al., 2015; Harrington et al., 1997) .
Studies on the heritability of AO itself have also yielded conflicting results. One twin study reported an AO heritability estimate of 0.47 (Lyons et al., 1998) , whereas another observed AO to be primarily due to environmental factors (Kendler et al., 1992) . It is of note that a pair of Swedish twin studies found a modest association of AO with familial liability to MD (Kendler et al., 2005 (Kendler et al., , 2009 ), but other twin studies of Swedish and English samples have failed to confirm this finding (Kendler et al., 1994; Kendler, Gardner, & Prescott, 1999; McGuffin, Katz, Watkins, & Rutherford, 1996) . Using molecular data on common variants, preliminary research thus far has found a marginally significant single nucleotide polymorphism (SNP)-based heritability estimate of .17 (P = .04 ; Ferentinos et al., 2015) for presence/absence of early AO. A genome-wide association study has examined AO of MD as a quantitative trait (in European samples with mean AO of ∼20 years of age, N < 2,000 cases and controls; Power et al., 2012) . Although specific genome-wide hits did not replicate, results did suggest that common genetic variants may explain a large portion of the variance in AO in European samples (55%, P = .02). Finally, in a report by the Psychiatric Genomics Consortium working group, polygenic score analyses across mixed-ancestry samples suggested that earlier-onset MD is genetically more similar to major psychiatric disorders such as schizophrenia and bipolar disorder than is adult-onset MDD. A potential implication of this finding is an increased genetic loading for MD in earlier-onset cases (Power et al., 2017) .
Further examination of molecular genomic data may help to clarify whether AO is a heritable phenotype and whether it is associated with genetic liability to MD. Additional research is also needed to assess whether common variant heritability of AO may be significant in non-European samples. The China, Oxford and VCU Experimental Research on Genetic Epidemiology (CONVERGE) group recently detected and replicated the first robustly genome-wide statistically significant association between specific molecular variants and MD (CONVERGE Consortium, 2015) . In addition, earlier age at worst episode was significantly associated with telomere shortening in this sample . In the context of this success, it is useful to maximize statistical power and to examine AO as a potentially relevant quantitative phenotype. This includes (1) the examination of dimensional, aggregated effects from all measured common genetic variants in over 10,000 cases and controls, and (2) the examination of AO as both a continuous and a binary (early/late) phenotype.
Dimensional examination of aggregated effects across the genome has been useful in the examination of several complex phenotypes such as affective disorders, Parkinson's disease, and autism (Klei et al., 2012; Visscher et al., 1999; Zhang, Martin, Morris, & Li, 2009 ). Analyses of other phenotypes have illustrated how a significant proportion of the genetic variance impacting complex traits, though not at genome-wide significance thresholds, can be detected with genetic profile scoring approaches and with genome-wide complex trait analysis (GCTA; Yang, Lee, Goddard, & Visscher, 2011) .
This study sought to test the hypotheses that (1) continuous AO is a demonstrably heritable quantitative phenotype, and (2) that earlier AO reflects increased polygenic risk for MD. GCTA was first conducted with the entire MD case sample examining AO as a continuous variable. This research also examined whether polygenic risk for MD, derived using best linear unbiased predictor (BLUP) scores in split-half samples, predicted AO. In addition, the case sample was divided at the AO median, and estimates of SNP-based heritability were compared across groups. Each AO group (early vs. late) was also compared to the entire set of controls to determine whether AO groups would differ in subsequent SNP-based heritability estimates of MD. MD BLUP score distributions across very low AO (<16) and median split AO groups (<34 and ≥34) were directly compared with nonparametric tests of equal densities. Finally, AO was compared across cases with and without a positive history of MD in first-degree relatives. (CONVERGE Consortium, 2015) . Due to some evidence that heritability of MDD differs by sex (Bierut et al., 1999; Kendler, Gardner, & Prescott, 2001; Kendler, Gatz, Gardner, & Pedersen, 2006) , we controlled for potential clinical and etiologic heterogeneity by collecting only female participants. To reduce population stratification, only participants only whose grandparents (all four) were of Han Chinese descent were recruited. Cases were excluded for history of bipolar disorder, any psychosis, and any significant mental disability such as a diagnosis of mental retardation. AO data were missing for 55 of the cases.
MATERIALS AND METHODS

Sample ascertainment
All cases were recruited to be between 30 and 60 years of age and had at least two major depressive episodes, with the first episode occurring prior to age 50. Prior research supports a greater genetic loading for MDD in more strictly ascertained cases, and the resultant assurance of MDD case status based on recurrence is strength of this sample. Moreover, research on recurrent cases here is consistent with sampling methods from the previous molecular studies on AO (Ferentinos et al., 2015; Power et al., 2012 Power et al., , 2017 ).
Cases could not have abused drugs or alcohol prior to their first episode of depression. All subjects were interviewed using computerized assessment administered by a trained clinician, Axis I disorders were assessed, and all cases met diagnostic criteria for major depressive disorder. All of the clinical data were collected through faceto-face interviews by trained interviewers with clinical backgrounds.
The interviewing process was recorded and monitored by experienced supervisors who provided feedback to ensure continued high-quality interviewing.
Diagnoses of depressive disorders were completed using the elsewhere, indicating that the DSM criteria perform similarly in this sample relative to the European and U.S. samples (Kendler et al., 2015) . Representativeness of the sample with regard to severity, chronicity, and number of depressive episodes has also been reported previously, and the mean illness duration of this sample was 9.75 years (Li et al., 2012) .
The diagnostic interview was originally translated into Mandarin by a team of psychiatrists in Shanghai Mental Health Center, with the translation reviewed and modified by members of the CONVERGE team. Although cases were excluded for schizophreniaspectrum/bipolar disorders, anxiety disorders were comorbid with many of the depression diagnoses, and these comorbidities have been examined and reported previously (Kendler et al., 2015) . The mean number of comorbid anxiety disorders among the MDD patients was 1.35 (SD = 1.56).
The history of lifetime MD in parents and siblings was assessed using the Family History Research Diagnostic criteria (Yang et al., 2014) and was adapted from the interview used in the Virginia Adult Twin Study of Psychiatric and Substance Use Disorders (Endicott, Andreasen, & Spitzer, 1975) . It should be noted that underreporting of family history (FH) can be present in nonfamily studies where multiple informants are unavailable for assessment. However, using diagnostic criteria in case-control designs, as was done here, significantly increases the sensitivity of FH reporting (Andreasen, Endicott, Spitzer, & Winokur, 1977) . AO was assessed retrospectively by the participants' self-report, and was defined as the age at which the first manifestation of a depressive episode occurred based on the MD diagnostic criteria assessed during the interview. Clinical characteristics as they relate to AO have been examined previously in this sample, with earlier AO being associated with increased neuroticism and greater psychiatric comorbidity (Li et al., 2012) . 
DNA sequencing
DNA extraction and sequencing details have previously been reported (Weissman, Gershon et al., 1984) . Briefly, DNA was extracted from saliva using Oragene and sequenced reads were 
Calling and imputation of genotypes
Details of genotype calling and imputation from low pass sequencing data are detailed elsewhere (Weissman, Gershon et al., 1984) . In brief, 6,242,619 SNPs were available after quality control, which included 
Statistical analyses
GCTA was used to construct a genetic relationship matrix (GRM) containing identical by state (IBS) relationship calculations for all pair-wise sets of individuals. The first two principal components of ancestry were included as covariates. Restricted maximum likelihood (REML) analyses were then performed using the GRM and quantitative principal component covariates. GCTA typically requires a sample size of N = 5,000 for a well-powered heritability analysis, thus CONVERGE is the only non-European depression sample to our knowledge that is large enough for such an examination. Genetic profile scores (or polygenic scores) were constructed using estimated common SNP effects by the BLUP method, using a random half of the sample (in the analysis of AO, the case sample; and in the analysis of MD, the entire sample) and testing the prediction of the phenotype from the training half on the remaining half. We then reversed the analysis to predict AO or MD status in the first half of the sample from polygenic data in the second half.
Linear regressions were conducted in R including a full model (e.g., BLUP score and the two primary principal components as predictors) and a restricted model, removing the BLUP score. The difference in Nagelkerke R 2 between the models (rsq) was computed and the P-value associated with the SNP-based score variable from the full model was examined. The Nagelkerke rsq generated from these models is a difference in pseudo-R , thus P values are not derived from full and restricted model comparisons. Instead, the P-value associated with the dropped component (score) is reported here. We then performed nonparametric density tests to examine score distribution overlap across three AO groups: <16 years of age, F I G U R E 1 Kernel density plot of age at onset in CONVERGE major depression cases 
TA B L E 1 Heritability of continuous AO across case groups
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RESULTS
Age of onset as a continuous phenotype
The distribution of AO across the entire CONVERGE case sample is presented in Figure 1 . SNP-based heritability of AO, as a continuous quantitative trait, was examined in the full case sample and in the split-half case samples, and these SNP-based heritabilities are presented in Table 1 . All were nonsignificant, despite adequate power in this sample to detect genetic effects. The results in Table 1 present V G /V P , or the proportion of total variance due to genetic factors (standardized genetic variance) in each sample. Despite small SEs, heritability estimates were negligible.
Split-half case-control samples were used to create MD BLUP scores, and these scores were used to predict AO in the cases as a quantitative phenotype. AO did not significantly vary as a function of BLUP score when regression models with and without BLUP score, accounting for ancestry principle components, were directly compared. Scores in the cases were also uncorrelated with AO as a quantitative phenotype ( = −.01, P = .48). Because this was a large sample, it was also possible to examine age cohort effects by restricting the sample to individuals 50 and above, and there was no significant correlation of BLUP score with AO in these cases ( = 0.02, P = .52).
Age of onset by median split
In this sample, mean AO was 35.9 and the median was 34; AO was likely somewhat high relative to other samples due to cases being at least 30 years of age. We elected to test whether groups divided by the median would differ in SNP-based heritability of MD. The MD sample was divided by AO into low-half AO (<34 years), yielding 2,767 cases; and high-half AO (≥34 years), yielding 2,578 case samples.
Results of heritability analyses for these samples are presented in Table 2 , showing that the SNP-based heritability of MD of earlier AO was estimated at 19% (SE = 0.03) and for MD at later AO, SNP-based heritability was estimated at 22% (SE = 0.04). For illustrative purposes, and to examine the smaller group of very early onset (<16 years of age), distributions of BLUP scores for the samples with AO < 16 and AO ≥ 34 are presented in Figure 2 . These distributions can be seen to overlap almost entirely, indicating minimal genetic association of MD with AO. All nonparametric tests of equal densities were nonsignificant, indicating that no two AO groups (AO <16, <34, and ≥ 34) differed with respect to distribution of BLUP score. to test whether AO heritabilities differed in samples with and without TA B L E 2 GCTA of MD across median-split AO cases and across family history Note: AO, age at onset; FH, family history of depression; MD, major depression; LRT, likelihood ratio test; V G , genetic variance; V E , environmental variance; V P , total phenotypic variance; V G /V P , proportion of total variance due to genetic factors (standardized genetic variance); SE, standard error. Group A reflects the case sample meeting below or above median AO status, or present or absent FH. Group 2 reflects the entire group of controls. The P-value here reflects the test of whether the proportion of variance in MD accounted for by SNP-based genetic factors V(G)/V(P) is statistically significant. In all cases, quantitative MD heritability based on common SNPs is significant, but heritabilities are roughly equivalent across tests of the different subgroups, indicating little variation in MD SNP-based genetic factors by AO or FH.
Age of onset and FH of MD
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F I G U R E 2
Major depression best linear unbiased predictor score densities across <16 and ≥ 34 AO groups. The solid line reflects cases with age at onset <16, the dotted line reflects age at onset of the median (34) and above. The band reflects upper and lower endpoints of the reference band for equality. This test of equal densities is a permutation test, where the SE of the sum of the squared differences of the density distributions is used to paint the band shown here. This plot conveys that the distributions of polygenic scores across groups of early and high AO groups are roughly equivalent self-reported FH, the tests of AO SNP-based heritabilities in this sample were nonsignificant. Case samples with and without FH did not differ with respect to BLUP score (P = .23).
DISCUSSION
This well-powered study leveraged molecular data as an alternative to estimating heritability based on biometrical models in an effort to resolve the previous contradictory findings on AO. This study examined whether earlier AO reflects increased genetic liability for MD as measured by (1) , consistent with a lack of robust relationship between SNP-based polygenicity for MD and quantitative AO. 
CONCLUSIONS
